Publikationen von Sucker, Antje

Zaremba, Anne, Philip, Manuel, Hassel, Jessica C., Glutsch, Valerie, Fiocco, Zeno, Loquai, Carmen, Rafei-Shamsabadi, David , Gutzmer, Ralf, Utikal, Jochen, Haferkamp, Sebastian , Reinhardt, Lydia, Kähler, Katharina C., Weishaupt, Carsten, Moreira, Alvaro, Thoms, Kai-Martin, Wilhelm, Tabea, Pföhler, Claudia, Roesch, Alexander, Ugurel, Selma, Zimmer, Lisa , Stadtler, Nadine, Sucker, Antje, Kiecker, Felix, Heinzerling, Lucie, Meier, Friedegund, Meiss, Frank, Schlaak, Max, Schilling, Bastian, Horn, Susanne, Schadendorf, Dirk und Livingstone, Elisabeth (2021) Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases. European Journal of Cancer 152, S. 139-154. Volltext nicht vorhanden.

Liu, David, Schilling, Bastian , Liu, Derek, Sucker, Antje, Livingstone, Elisabeth, Jerby-Arnon, Livnat, Zimmer, Lisa, Gutzmer, Ralf, Satzger, Imke, Loquai, Carmen, Grabbe, Stephan, Vokes, Natalie, Margolis, Claire A., Conway, Jake, He, Meng Xiao, Elmarakeby, Haitham , Dietlein, Felix, Miao, Diana, Tracy, Adam, Gogas, Helen, Goldinger, Simone M., Utikal, Jochen, Blank, Christian U., Rauschenberg, Ricarda, von Bubnoff, Dagmar, Krackhardt, Angela, Weide, Benjamin, Haferkamp, Sebastian, Kiecker, Felix, Izar, Ben, Garraway, Levi, Regev, Aviv, Flaherty, Keith, Paschen, Annette, Van Allen, Eliezer M. und Schadendorf, Dirk (2019) Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nature Medicine 25 (12), S. 1916-1927. Volltext nicht vorhanden.

Pieper, Natalia, Zaremba, Anne, Leonardelli, Sonia, Harbers, Franziska Noelle, Schwamborn, Marion, Lübcke, Silke, Schrörs, Barbara, Baingo, Jolanthe, Schramm, Alexander, Haferkamp, Sebastian, Seifert, Ulrike, Sucker, Antje, Lennerz, Volker, Wölfel, Thomas, Schadendorf, Dirk, Schilling, Bastian, Paschen, Annette und Zhao, Fang (2018) Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment. OncoImmunology, e1450127. Volltext nicht vorhanden.